Vir Biotechnology, Inc. VIR Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s preferred stock, par or stated value per share?
- Vir Biotechnology, Inc. (VIR) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Vir Biotechnology, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Vir Biotechnology, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Vir Biotechnology, Inc.'s preferred stock, par or stated value per share?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.